MarketCap
Facebook
X
TelegramQuarterly report 2022-Q1
added 12-16-2023
R1 RCM Cash Conversion Cycle 2011-2025 | RCM
Annual Cash Conversion Cycle R1 RCM
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 21.9 | 13.8 | 8.98 | 6.54 | -1.7 | -10.9 | 20.3 | -17.3 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 21.9 | -17.3 | 5.19 |
Quarterly Cash Conversion Cycle R1 RCM
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 23.2 | - | 18.8 | 18.1 | 18.2 | - | 18.9 | 17.5 | 12.3 | 15.2 | 8.22 | 8.69 | 9.84 | 14.7 | 11.3 | 13.8 | 9.99 | 5.33 | 0.19 | 0.71 | 6.41 | - | 16.1 | - | 1.89 | - | - | - | - | - | - | - | - | - | - | - | - | - | 10.2 | 8.53 | 6.81 | 19.5 | 39.2 | 46.8 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 46.8 | 0.19 | 14.1 |
Cash Conversion Cycle of other stocks in the Health information services industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cerner Corporation
CERN
|
-20 | - | - | $ 27.9 B |  USA |
 |
Computer Programs and Systems
CPSI
|
43.2 | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
52.1 | - | - | $ 2.94 B | USA |
 |
Accolade
ACCD
|
-4.64 | - | 0.29 % | $ 206 M | USA |
 |
Castlight Health, Inc.
CSLT
|
68.7 | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
-587 | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
56.1 | - | - | $ 6.37 B | USA |
 |
Change Healthcare
CHNG
|
87 | - | - | $ 9.03 B | USA |
 |
Evolent Health
EVH
|
183 | $ 4.07 | 3.17 % | $ 381 M | USA |
 |
Health Catalyst
HCAT
|
50 | $ 2.45 | -4.3 % | $ 147 M | USA |
 |
HealthStream
HSTM
|
14.1 | $ 24.19 | -0.62 % | $ 735 M | USA |
 |
iCAD
ICAD
|
117 | - | - | $ 102 M | USA |
 |
Akerna Corp.
KERN
|
-89.4 | - | - | $ 161 M | USA |
 |
HealthEquity
HQY
|
92.5 | $ 97.98 | 0.61 % | $ 8.38 B | USA |
 |
American Well Corporation
AMWL
|
90 | $ 4.51 | 3.2 % | $ 67.6 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
71 | - | -10.39 % | $ 886 M | USA |
 |
MTBC
MTBC
|
40.6 | - | -0.58 % | $ 51.7 M | USA |
 |
GoodRx Holdings
GDRX
|
-124 | $ 2.84 | 1.79 % | $ 1.1 B | USA |
 |
Omnicell
OMCL
|
112 | $ 43.75 | 1.05 % | $ 2.01 B | USA |
 |
1Life Healthcare
ONEM
|
39.8 | - | - | $ 3.37 B | USA |
 |
OptimizeRx Corporation
OPRX
|
125 | $ 13.45 | -4.13 % | $ 230 M | USA |
 |
Progyny
PGNY
|
121 | $ 26.65 | 2.46 % | $ 2.29 B | USA |
 |
Phreesia
PHR
|
1.78 | $ 16.16 | 0.75 % | $ 882 M | USA |
 |
Premier
PINC
|
110 | $ 28.26 | - | $ 2.33 B | USA |
 |
Signify Health
SGFY
|
214 | - | -0.02 % | $ 7.21 B | USA |
 |
So-Young International
SY
|
87 | $ 3.06 | -1.61 % | $ 243 M |  China |
 |
NantHealth
NH
|
-54.1 | - | -46.64 % | $ 10.4 M | USA |
 |
NextGen Healthcare
NXGN
|
37.1 | - | - | $ 1.6 B | USA |
 |
Schrödinger
SDGR
|
199 | $ 18.05 | -0.44 % | $ 1.31 B | USA |
 |
Zhongchao
ZCMD
|
-1.06 | $ 0.62 | 0.6 % | $ 3.23 M | China |
 |
Streamline Health Solutions
STRM
|
59.4 | - | - | $ 21.4 M | USA |
 |
Teladoc Health
TDOC
|
28.4 | $ 7.58 | -0.59 % | $ 1.29 B | USA |
 |
10x Genomics
TXG
|
167 | $ 15.57 | -5.86 % | $ 1.82 B | USA |
 |
Tabula Rasa HealthCare
TRHC
|
12 | - | - | $ 255 M | USA |
 |
Veeva Systems
VEEV
|
100 | $ 223.05 | -2.81 % | $ 35.8 B | USA |
 |
SCWorx Corp.
WORX
|
41.4 | $ 0.21 | -3.41 % | $ 306 K | USA |